Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphoma

Journal of Leukocyte Biology

Volumn 75, Issue 2, 2004, Pages 207-213

  Dayyani, Farshid ^a   Joeinig, Anke ^a   Ziegler Heitbrock, Löms ^b,c   Schmidmaier, Ralf ^a   Straka, Christian ^a   Emmerich, Bertold ^a   Meinhardt, Gerold ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Oxidative burst; Phagocytosis; TNF

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CARMUSTINE; CD14 ANTIGEN; CD16 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; FLUORESCEIN ISOTHIOCYANATE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IDARUBICIN; IFOSFAMIDE; INTERLEUKIN 10; MELPHALAN; MITOXANTRONE; MYELOABLATIVE AGENT; PREDNIMUSTINE; PREDNISONE; PROCARBAZINE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MEGADOSE; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LEUKOCYTE COUNT; LEUKOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; MALE; MONOCYTE; MYELOMA; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

ADULT; AGED; ANTIGENS, CD14; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-DR ANTIGENS; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE MYELOMA; PHAGOCYTOSIS; RECEPTORS, IGG; RESPIRATORY BURST; TRANSPLANTATION, AUTOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI;

EID: 0842331522     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0803386     Document Type: Article

References (26)

1. Gratwohl, A., Passweg, J., Baldomero, H., Hermans, J. (1999) Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 24, 231-245.
2. Grosbois, B., Decaux, O., Azais, I., Facon, T., Avet-Loiseau, H. (2002) Current treatment strategies for multiple myeloma. Eur. J. Intern. Med. 13, 85-95.
3. Reimer, P., Kunzmann, V., Wilhelm, M., Weissbrich, B., Kraemer, D., Berghammer, H., Weissinger, F. (2003) Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT). Ann. Hematol. 82, 263-270.
4. Schlenke, P., Sheikhzadeh, S., Weber, K., Wagner, T., Kirchner, H. (2001) Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 28, 251-257.
5. Akpek, G., Lenz, G., Lee, S. M., Sanchorawala, V., Wright, D. G., Colarusso, T., Waraska, K., Lerner, A., Vosburgh, E., Skinner, M., Comenzo, R. L. (2001) Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloidosis. Bone Marrow Transplant. 28, 1105-1109.
6. Flieger, D., Ziegler-Heitbrock, H. W. (1988) Abnormal blood monocytes in chronic lymphocytic leukemia. Cancer Res. 48, 4812-4816.
7. Dammacco, F., Miglietta, A., Ventura, M. T., Bonomo, L. (1982) Defective monocyte chemotactic responsiveness in patients with multiple myeloma and benign monoclonal gammapathy. Clin. Exp. Immunol. 47, 481-486.
8. Mainwaring, C. J., Williams, M. A., Singer, C. R., Lush, R. J., Smith, J. G., Haynes, C. L., Kelsey, S. M. (1999) Monocyte dysfunction in patients with multiple myeloma and lymphoplasmacytic disorders is related to serum paraprotein levels. Br. J. Haematol. 105, 948-954.
9. Williams, M. A., Rhoades, C. J., Newland, A. C., Kelsey, S. M. (1999) The potential for monocyte-mediated immunotherapy during infection and malignancy. Leuk. Lymphoma 34, 207-230.
10. Grage-Griebenow, E., Flad, H. D., Ernst, M. (2001) Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69, 11-20.
11. Passlick, B., Flieger, D., Ziegler-Heitbrock, H. W. (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534.
12. Ziegler-Heitbrock, H. W. (1996) Heterogeneity of human blood monocytes; the CD14+ CD16+ subpopulation. Immunol. Today 17, 424-428.
13. Kawanaka, N., Yamamura, M., Aita, T., Morita, Y., Okamoto, A., Kawashima, M., Iwahashi, M., Ueno, A., Ohmoto, Y., Makino, H. (2002) CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 46, 2578-2586.
14. + monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 85, 2910-2917.
15. Beige, K. U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T., Ziegler-Heitbrock, L. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168, 3536-3542.
16. Frankenberger, M., Sternsdorf, T., Pechumer, H., Pforte, A., Ziegler-Heitbrock, H. W. (1996) Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 87, 373-377.
17. Ancuta, P., Rao, R., Moses, A., Mehle, A., Shaw, S. K., Luscinskas, F. W., Gabuzda, D. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197, 1701-1707.
18. Geissmann, F., Jung, S., Littman, D. R. (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82.
19. Petersen, J., Drivsholm, A., Brandt, M., Ambjornsen, A., Dickmeiss, E. (1989) B lymphocyte function in multiple myeloma: analysis of T cell- and monocyte-dependent antibody production. Eur. J. Haematol. 42, 193-201.
20. Rawstron, A. C., Davies, F. E., Owen, R. G., English, A., Pratt, G., Child, J. A., Jack, A. S., Morgan, G. J. (1998) B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors. Br. J. Haematol. 100, 176-183.
21. Ohsaka, A., Saionji, K., Kuwaki, T., Takeshima, T., Igari, J. (1995) Granulocyte colony-stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes. Br. J. Haematol. 89, 465-472.
22. Tanaka, M., Honda, J., Imamura, Y., Shiraishi, K., Tanaka, K., Oizumi, K. (1999) Surface phenotype analysis of CD16+ monocytes from leukapheresis collections for peripheral blood progenitors. Clin. Exp. Immunol. 116, 57-61.
23. Ratta, M., Fagnoni, F., Curti, A., Vescovini, R., Sansoni, P., Oliviero, B., Fogli, M., Ferri, E., Della Cuna, G. R., Tura, S., Baccarani, M., Lemoli, R. M. (2002) Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood 100, 230-237.
24. Brown, R. D., Pope, B., Murray, A., Esdale, W., Sze, D. M., Gibson, J., Ho, P. J., Hart, D., Joshua, D. (2001) Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10. Blood 98, 2992-2998.
25. Baseggio, L., Bienvenu, J., Charlot, C., Picollet, J., Felman, P., Coiffier, B., Salles, G. (2001) Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients. Exp. Hematol. 29, 330-338.
26. Reinke, P., Bevilacqua, M., Tryon, V., Cheronis, J., Volk, H. D. (2002) Immune monitoring of glucocorticoid therapy. Ernst Schering Res. Found. Workshop 40, 25-37.